Register Menu Close

Theresa Wang

Clinical Quality and Compliance Management Director AstraZeneca

Theresa Wang has over 17 years’ experience in clinical industry, including global study & program management and quality management in global CRO and pharma MNC. From Dec 2023, Theresa has worked as IFPMA ICH E21 taskforce leader to drive the collaborative efforts from IFPMA and work closely with ICH EWG experts to bring the guideline to step 3 public consultation. E21 guideline will deliver tremendous value to pregnant and breastfeeding individuals by supporting fair and informed treatment with clear benefit–risk understanding.

See Theresa Wang at this event

  • Webinar 2 Thursday 2 October

Session 2: Project initiatives supporting inclusivity

13:45 - 14:30 CET

Presentation of project initiatives

  • Pediatrics & Pregnant Women in Clinical Trials – Mariana Widmer & Martina Penazzato, WHO
  • Malaria in Mothers and Babies (MiMBa) – Myriam El Gaaloul, Medicines for Malaria Venture
  • ICH E21: Inclusion of Pregnant and Breast-feeding Individuals in Clinical Trials – Theresa Wang, on behalf of IFPMA

Speakers